We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: β-glucans present promise as adjuvants for allergy remedy
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > β-glucans present promise as adjuvants for allergy remedy
β-glucans present promise as adjuvants for allergy remedy
Health

β-glucans present promise as adjuvants for allergy remedy

Last updated: February 1, 2025 5:44 pm
Editorial Board Published February 1, 2025
Share
SHARE

β-glucans upregulate the expression of the sample recognition receptors TLR2 and Dectin-1 on mDCs. Bone marrow of C57BL/6 mice was remoted and differentiated for 8 days into mDCs that had been subsequently stimulated with both 12 µg/mL of the indicated β-glucans or 10 µg/mL LPS as a constructive management for twenty-four h . Credit score: Worldwide Journal of Molecular Sciences (2024). DOI: 10.3390/ijms25189914

A current examine carried out by a analysis workforce from the Paul-Ehrlich-Institut investigated the immunomodulating properties of β-glucans. These are pure sugar compounds present in micro organism, fungi and grains. The outcomes point out that β-glucans can goal the immune system and modulate pro-inflammatory responses. Their potential to suppress allergic reactions and supply new approaches to allergy remedy is especially promising. The analysis was printed within the Worldwide Journal of Molecular Sciences.

β-glucans’ potential as an adjuvant is especially promising. One use for adjuvants is as a vaccine ingredient to strengthen the immune response and thus strengthen vaccination safety.

Adjuvants are additionally used for therapeutic allergens, which help in influencing (modulating) the immune system in a approach that contributes to decreasing the allergic reactions and to serving to the affected person adapt to the allergen.

Allergen-specific immunotherapy includes researching adjuvants to be able to modulate allergen-specific (generally known as Th2) immune reactions in a focused method and to re-establish tolerance towards sure allergens.

A analysis group led by PD Dr. Stefan Schülke, head of the Analysis Allergology Division on the Paul-Ehrlich-Institut performed a examine to check six completely different β-glucans, together with zymosan and its variants, in addition to different identified β-1,3 glucans for his or her affect on the immune system.

The group discovered that these substances activate completely different immune cells and affect the discharge of sure pro-inflammatory substances in several methods. Zymosan and β-1,3 glucan particularly had been capable of scale back the manufacturing of inflammatory markers within the experiments and confirmed a promising means to suppress allergy-related immune responses.

The outcomes of the examine are promising and will assist to develop new therapeutic approaches for the remedy of allergy symptoms. Sooner or later, β-glucans may play an vital position in stopping allergic reactions and controlling the immune response in a focused method.

Highlighted leads to element

The examine analyzed each immunological (receptor activation, cytokine secretion, T-cell modulation) and metabolic parameters (metabolic state) in dendritic cells—particular immune cells—derived from the bone marrow of mice. It was discovered that the entire β-glucans examined activated the C-type lectin receptor (CLR) Dectin-1a, whereas the “Toll”-like receptor 2 (TLR2) was significantly strongly triggered by zymosan. The β-glucans additionally led to completely different levels of cytokine secretion and activation of cell metabolism within the dendritic cells.

A extra detailed examine of the β-glucans zymosan, β-1,3 glucan and β-1,3/1,6 glucan confirmed that these β-glucans elevated the activation of the dendritic cells and upregulated the vital floor markers CD40, CD80, CD86 and MHCII to various levels. One other discovering: the cytokine secretion induced by β-glucans was partly depending on the activation of the intracellular Dectin-1 adapter molecule Syk.

In co-cultures of dendritic cells with mouse T cells sensitized to the main birch pollen allergen Guess v 1, 4 of the β-glucans examined suppressed allergen-induced IL-5 secretion. Nonetheless, solely zymosan and β-1,3 glucan considerably diminished the secretion of interferon gamma (IFNγ). This implies that the β-glucans examined have completely different impacts on the flexibility of dendritic cells to focus on T cells for allergens.

Extra info:
Hannah Rainer et al, Characterization of the Immune-Modulating Properties of Totally different β-Glucans on Myeloid Dendritic Cells, Worldwide Journal of Molecular Sciences (2024). DOI: 10.3390/ijms25189914

Supplied by
Paul-Ehrlich-Institut

Quotation:
β-glucans present promise as adjuvants for allergy remedy (2025, January 31)
retrieved 1 February 2025
from https://medicalxpress.com/information/2025-01-glucans-adjuvants-allergy-treatment.html

This doc is topic to copyright. Other than any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:adjuvantsallergypromiseShowtreatmentβglucans
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Projecting the Yankees’ potential Wild Card roster as division chase continues
Sports

Projecting the Yankees’ potential Wild Card roster as division chase continues

Editorial Board September 27, 2025
Examine suggests round 1 in 5 UK medical college students considers dropping out: Psychological well being is essential contributor
Our 7 Favourite Vacation Cocktails to Toast Actually Every little thing
The newest state of the sport jobs market | Amir Satvat
Figuring out a compass within the human mind

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?